To date phogrin has been widely used as one of the major auto-antigens in diabetes mellitus type I (Kawasaki et al., 1996; Lu et al., 1996) and in the CNS, phogrin expression has been proposed to be developmentally regulated (Chiang and Flanagan, 1996). The gene discussed is PTPRN2; the disease is type 1 diabetes mellitus.